Annual ROE
-50.19%
-9.97%-24.79%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual return on equity is -50.19%, with the most recent change of -9.97% (-24.79%) on December 31, 2023.
- During the last 3 years, KROS annual ROE has fallen by -15.59% (-45.06%).
- KROS annual ROE is now -379.83% below its all-time high of -10.46%, reached on December 31, 2018.
Performance
KROS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.60%
+1.34%+2.92%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly return on equity is -44.60%, with the most recent change of +1.34% (+2.92%) on September 30, 2024.
- Over the past year, KROS quarterly ROE has increased by +3.61% (+7.49%).
- KROS quarterly ROE is now -83.31% below its all-time high of -24.33%, reached on December 31, 2021.
Performance
KROS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KROS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.8% | +7.5% |
| 3 y3 years | -45.1% | -56.3% |
| 5 y5 years | -379.8% | - |
KROS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -115.7% | at low | -83.3% | +7.5% |
| 5 y | 5-year | -115.7% | +73.0% | -83.3% | +98.2% |
| alltime | all time | -379.8% | +73.0% | -83.3% | +98.2% |
Keros Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -44.60%(-2.9%) |
| Jun 2024 | - | -45.94%(+1.1%) |
| Mar 2024 | - | -45.46%(-5.7%) |
| Dec 2023 | -50.19%(+24.8%) | -48.21%(+1.2%) |
| Sep 2023 | - | -47.63%(+6.2%) |
| Jun 2023 | - | -44.84%(+0.9%) |
| Mar 2023 | - | -44.45%(+1.6%) |
| Dec 2022 | -40.22% | -43.75%(+21.5%) |
| Sep 2022 | - | -36.00%(+3.6%) |
| Jun 2022 | - | -34.76%(+21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -28.67%(+17.8%) |
| Dec 2021 | -23.27%(-32.7%) | -24.33%(-14.7%) |
| Sep 2021 | - | -28.53%(+7.1%) |
| Jun 2021 | - | -26.63%(-10.1%) |
| Mar 2021 | - | -29.62%(-23.6%) |
| Dec 2020 | -34.60%(-81.4%) | -38.76%(-16.3%) |
| Sep 2020 | - | -46.29%(+2.7%) |
| Jun 2020 | - | -45.07%(-45.0%) |
| Mar 2020 | - | -81.97%(-96.7%) |
| Dec 2019 | -186.16%(+1679.7%) | -2492.12% |
| Dec 2018 | -10.46% | - |
FAQ
- What is Keros Therapeutics annual return on equity?
- What is the all time high annual ROE for Keros Therapeutics?
- What is Keros Therapeutics annual ROE year-on-year change?
- What is Keros Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Keros Therapeutics?
- What is Keros Therapeutics quarterly ROE year-on-year change?
What is Keros Therapeutics annual return on equity?
The current annual ROE of KROS is -50.19%
What is the all time high annual ROE for Keros Therapeutics?
Keros Therapeutics all-time high annual return on equity is -10.46%
What is Keros Therapeutics annual ROE year-on-year change?
Over the past year, KROS annual return on equity has changed by -9.97% (-24.79%)
What is Keros Therapeutics quarterly return on equity?
The current quarterly ROE of KROS is -44.60%
What is the all time high quarterly ROE for Keros Therapeutics?
Keros Therapeutics all-time high quarterly return on equity is -24.33%
What is Keros Therapeutics quarterly ROE year-on-year change?
Over the past year, KROS quarterly return on equity has changed by +3.61% (+7.49%)